Anti-inflammatory Activity of Water Extract of Luvunga sarmentosa (BI.) Kurz Stem in the Animal Models

Sabar Deyulita (1) , Hilkatul Ilmi (2) , Hanifah Khairun Nisa (3) , Lidya Tumewu (4) , Aty Widyawaruyanti (5) , Achmad Fuad Hafid (6)
(1) Universitas Airlangga , Indonesia
(2) Universitas Airlangga , Indonesia
(3) Universitas Airlangga , Indonesia
(4) Universitas Airlangga , Indonesia
(5) Universitas Airlangga , Indonesia
(6) Universitas Airlangga , Indonesia

Abstract

The study was aimed to determine the anti-inflammatory activity of water extract of the Luvunga sarmentosa stem in an animal model. Twenty-five Wistar rats were divided into five groups (n=5). Group 1 was administered 0.9% normal saline (negative control), group 2 was administered 150 mg/kg diclofenac sodium (positive control), and groups 3 to 5 were administered 50, 300, and 550 mg/kg BW of L. sarmentosa extract, respectively. Carrageenan was injected subcutaneously into each rat's subplantar region of the left hind paw. The paw volume was measured using a plethysmometer. The results showed that the water extract of L. sarmentosa stem (doses of 50, 300, and 550 mg/kg BW) significantly reduced the paw edema volume from the 4th to 5th hour compared to the negative control. The percent inhibition of edema at the 5th hour is 47.45; 46.95; 50.39%. The first phase of the edema (1st and 2nd hour) was not affected by the extract. Meanwhile, diclofenac sodium decreased paw edema volume from the 1st to 5th hour with a percent inhibition of 95.90% at the 5th hour. The histopathology result is relevant to the percentage inhibition of edema. Treatment with L. sarmentosa extract showed slight improvement, destruction of epidermal tissue, hyperkeratotic skin, and subepidermal edema. Meanwhile, positive control showed no inflammatory signs with normal keratin, subepidermal, and subcutaneous layers. The water extract of L. sarmentosa stem has anti-inflammatory activity. This extract effectively reduces the paw edema volume in the late phase with decreased neutrophil infiltration.

Full text article

Generated from XML file

References

1. Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017;9(6):7204-18. doi:10.18632/oncotarget.23208
2. Jargalsaikhan BE, Ganbaatar N, Urtnasan M, Uranbileg N, Begzsuren D. Anti-Inflammatory effect of polyherbal formulation (PHF) on carrageenan and lipopolysaccharide-induced acute inflammation in rats. Biomed Pharmacol J. 2019;12(4):1801–9. doi:10.13005/bpj/1811
3. Walter EJ, Hanna-Jumma S, Carraretto M, Forni L. The pathophysiological basis and consequences of fever. Crit Care. 2016;20:200. doi:10.1186/s13054-016-1375-5
4. Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. The crucial roles of inflammatory mediators in inflammation: A review. Vet World. 2018;11(5):627-35. doi:10.14202/vetworld.2018.627-635
5. Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822-32. doi:10.1038/s41591-019-0675-0
6. Bennett JM, Reeves G, Billman GE, Sturmberg JP. Inflammation-Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing "the Epidemic" of Chronic Diseases. Front Med. 2018;5:316. doi:10.3389/fmed.2018.00316
7. DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139(Suppl 2):136-53. doi:10.1111/jnc.13607
8. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020;180:114147. doi:10.1016/j.bcp.2020.114147
9. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis. 2018;9(1):143-50. doi:10.14336/ad.2017.0306
10. Drini M. Peptic ulcer disease and non-steroidal anti-inflammatory drugs. Aust Prescr. 2017;40(3):91-3. doi:10.18773/austprescr.2017.037
11. Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: An Overview. Medicines. 2018;5(3):93. doi:10.3390/medicines5030093
12. Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 2016;31(8):984-91. doi:10.1093/heapol/czw022
13. Zulkipli IN, David SR, Rajabalaya R, Idris A. Medicinal Plants: A Potential Source of Compounds for Targeting Cell Division. Drug Target Insights. 2015;9:9-19. doi:10.4137/dti.s24946
14. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177. doi:10.3389/fphar.2013.00177
15. Salmerón-Manzano E, Garrido-Cardenas JA, Manzano-Agugliaro F. Worldwide Research Trends on Medicinal Plants. Int J Environ Res Public Health. 2020;17(10):3376. doi:10.3390/ijerph17103376
16. Wardah, Sundari S. Ethnobotany study of Dayak society medicinal plants utilization in Uut Murung District, Murung Raya Regency, Central Kalimantan. IOP Conf Ser Earth Environ Sci. 2019;298(1):012005. doi:10.1088/1755-1315/298/1/012005
17. Fauzi F, Widodo H. Short Communication: Aphrodisiac plants used by Dayak Ethnic in Central Kalimantan Province, Indonesia. Biodiversitas. 2019;20(7):1859-65. doi:10.13057/biodiv/d200710
18. Wati H, Muthia R, Jumaryatno P, Hayati F, August J. Phytochemical screening and aphrodisiac activity of Luvunga Sarmentosa (Bi.) Kurz ethanol extract in male wistar albino rats. Res J Pharm Biol Chem Sci. 2018;9(931):931–7.
19. Lien TP, Kamperdick C, Schmidt J, Adam G, Van Sung T. Apotirucallane triterpenoids from Luvunga sarmentosa (Rutaceae). Phytochemistry. 2002;60(7):747–54. doi:10.1016/s0031-9422(02)00156-5
20. Han YM, Woo S-U, Choi MS, Park YN, Kim SH, Yim H, et al. Antiinflammatory and analgesic effects of Eurycoma longifolia extracts. Arch Pharm Res. 2016;39(3):421–8. doi:10.1007/s12272-016-0711-2
21. Haddadi R, Rashtiani R. Anti-inflammatory and anti-hyperalgesic effects of milnacipran in inflamed rats: involvement of myeloperoxidase activity, cytokines and oxidative/nitrosative stress. Inflammopharmacology. 2020;28(4):903–13. doi:10.1007/s10787-020-00726-2
22. Rajput MA, Zehra T, Ali F, Kumar G. Evaluation of Antiinflammatory Activity of Ethanol Extract of Nelumbo nucifera Fruit. Turkish J Pharm Sci. 2021;18(1):56–60. doi:10.4274/tjps.galenos.2019.47108
23. Tatiya AU, Saluja AK, Kalaskar MG, Surana SJ, Patil PH. Evaluation of analgesic and anti-inflammatory activity of Bridelia retusa (Spreng) bark. J Tradit Complement Med. 2017;7(4):441-51. doi:10.1016/j.jtcme.2016.12.009
24. Patil KR, Mahajan UB, Unger BS, Goyal SN, Belemkar S, Surana SJ, et al. Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals. Int J Mol Sci. 2019;20(18):4367. doi:10.3390/ijms20184367
25. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–7. doi:10.3181/00379727-111-27849
26. Mansouri MT, Hemmati AA, Naghizadeh B, Mard SA, Rezaie A, Ghorbanzadeh B. A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian J Pharmacol. 2015;47(3):292–8. doi:10.4103/0253-7613.157127

Authors

Sabar Deyulita
Hilkatul Ilmi
Hanifah Khairun Nisa
Lidya Tumewu
Aty Widyawaruyanti
Achmad Fuad Hafid
achmadfuad@yahoo.com (Primary Contact)
1.
Deyulita S, Ilmi H, Nisa HK, Tumewu L, Widyawaruyanti A, Hafid AF. Anti-inflammatory Activity of Water Extract of Luvunga sarmentosa (BI.) Kurz Stem in the Animal Models. Borneo J Pharm [Internet]. 2022Feb.28 [cited 2024Dec.22];5(1):56-62. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/2968

Article Details